Cempra To Present Full Data Set Of Phase 2 Clinical Trial Of CEM-101 – RTT News

(RTTNews) – Cempra Inc. (CEMP: News ) said that data will be presented at the European Congress of Clinical Microbiology and Infectious Diseases or ECCMID, in London, demonstrating CEM-101’s efficacy to be comparable to levofloxacin in a Phase 2 trial of …

Leave a Reply

Your email address will not be published.